No photo of Arvydas Vanagunas

View Scopus Profile

Arvydas Vanagunas

  • 1377 Citations
1980 …2019

Research output per year

If you made any changes in Pure these will be visible here soon.

Personal profile

Research Interests

Endoscopic ultrasound, Ulcer disease

Certifications and Licenses

Internal Medicine
Gastroenterology

Training Experience

1974Internship, Northwestern University, McGaw Medical Center
1976Residency, Northwestern University, McGaw Medical Center (Northwestern Memorial Hospital)
1980Fellowship, Northwestern University, McGaw Medical Center (Northwestern Memorial Hospital)

Education/Academic qualification

MD, University of Illinois at Chicago

… → 1969

Research interests

  • Colon/Rectal Cancer
  • Diarrhea
  • Endoscopy
  • GI Bleeding
  • Peptic Ulcer Disease

Fingerprint Dive into the research topics where Arvydas Vanagunas is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 3 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Grants

Prot#S187.3.005: Open- Label Continuation Treatment, Study With Levodopa-Carbidopa Intestinal Gel in Subjects With Advanced Parkinsons Disease And Severe Motor Fluctuations Who Have Exhibited A Persistent And Positive Effect To Treatment In Previous Stud

Simuni, T., Vanagunas, A. & Zadikoff, C.

Quintiles, Inc., Solvay Pharmaceuticals, Inc.

2/1/10 → 1/31/16

Project: Research project

Protocol S187.3.003: Open Label, 12 Month Safety and Efficacy Study of Levodopa-Carbidopa Intestinal Gel in Levodopa-Responsive Parkinson's Disease Subjects

Simuni, T., Vanagunas, A. & Zadikoff, C.

Quintiles, Inc., Solvay Pharmaceuticals, Inc.

10/8/09 → 10/7/15

Project: Research project

Prot# S187.3.002: A Randomized, Double-Blind, Double-Dummy, Efficacy, Safety and Tolerability Study of Levodopa-Carbidopa Intestina Gel in Levodopa-Responsive Parkinson's Subjects Receiving Optimized Treatments with Parkinson Medicinal Products, Who Cont

Simuni, T., Vanagunas, A. & Zadikoff, C.

Quintiles, Inc., Solvay Pharmaceuticals, Inc.

8/6/09 → 8/5/12

Project: Research project

Prot# S187.3.004: Open-Label, 6-12 Months Safety and Efficacy Study of Levodopa-Carbidopa Intestinal Gel in Levodopa-Responsive Subjects with Advanced Parkinson's Disease and Severe Motor-Fluctuations

Simuni, T., Vanagunas, A. & Zadikoff, C.

Quintiles, Inc., Solvay Pharmaceuticals, Inc.

7/11/08 → 7/11/11

Project: Research project

Monitoring Respiratory Rate Based on Tracheal Sounds Using the Androflo? - Respiratory Rate Monitor

Lee, T. J. & Vanagunas, A.

Andromed Inc.

4/4/05 → 4/5/07

Project: Research project

Research Output

Reply to: DUOPA® is an Excellent Alternative Treatment but with Some Caveats

Burack, M., Aldred, J., Zadikoff, C., Vanagunas, A., Klos, K., Bilir, B., Fernandez, H. H. & Standaert, D. G., Apr 2019, In : Movement Disorders Clinical Practice. 6, 4, p. 336-337 2 p.

Research output: Contribution to journal › Letter

1 Scopus citations

Implementing Levodopa-Carbidopa Intestinal Gel for Parkinson Disease: Insights from US Practitioners

Burack, M., Aldred, J., Zadikoff, C., Vanagunas, A., Klos, K., Bilir, B., Fernandez, H. H. & Standaert, D. G., Jul 1 2018, In : Movement Disorders Clinical Practice. 5, 4, p. 383-393 11 p.

Research output: Contribution to journal › Review article

    • 4 Scopus citations

    Long-term safety and efficacy of levodopa-carbidopa intestinal gel in advanced Parkinson's disease

    Fernandez, H. H., Boyd, J. T., Fung, V. S. C., Lew, M. F., Rodriguez, R. L., Slevin, J. T., Standaert, D. G., Zadikoff, C., Vanagunas, A. D., Chatamra, K., Eaton, S., Facheris, M. F., Hall, C., Robieson, W. Z., Benesh, J. & Espay, A. J., Jun 2018, In : Movement Disorders. 33, 6, p. 928-936 9 p.

    Research output: Contribution to journal › Article

    • 10 Scopus citations

    Phlegmonous Gastritis: A Previously Unknown Complication of Listeria monocytogenes Infection

    Kelly, S. G., Vanagunas, A. D. & Dinh, M. H., Sep 1 2016, In : Infectious Diseases in Clinical Practice. 24, 5, p. e17-e19

    Research output: Contribution to journal › Article

    • 1 Scopus citations

    Continuous intrajejunal infusion of levodopa-carbidopa intestinal gel for patients with advanced Parkinson's disease: A randomised, controlled, double-blind, double-dummy study

    Olanow, C. W., Kieburtz, K., Odin, P., Espay, A. J., Standaert, D. G., Fernandez, H. H., Vanagunas, A., Othman, A. A., Widnell, K. L., Robieson, W. Z., Pritchett, Y., Chatamra, K., Benesh, J., Lenz, R. A. & Antonini, A., Feb 1 2014, In : The Lancet Neurology. 13, 2, p. 141-149 9 p.

    Research output: Contribution to journal › Article

    • 309 Scopus citations